Suppr超能文献

疟疾重症监护死亡率(MIMIC)

Mortality in Malaria: Intensive Care (MIMIC).

作者信息

Trivedi Trupti, Bajaj Poonam, Moulick Nivedita, Padwal Namita

机构信息

Associate Professor.

Ex-resident Doctor.

出版信息

J Assoc Physicians India. 2018 Apr;66(4):16-20.

Abstract

BACKGROUND

While global incidence of malaria has fallen in last decade, it continues to be an important cause of mortality and morbidity in acutely ill febrile patients. Many patients with complicated malaria require ICU care. In past it was believed that vivax is a benign form of malaria, but now all complications of malaria are reported in vivax. .

AIMS AND OBJECTIVES

  1. To find out proportion of patients with plasmodium vivax and plasmodium falciparum malaria requiring treatment in Medical ICU. 2. To compare clinical profile and severity of illness in these patients. 3. To study treatment received including organ support requirement in these patients and compare outcome in patients with vivax and falciparum malaria.

RESULTS

During study period total 932 patients were diagnosed as confirmed malaria (601 vivax, 240 falciparum and 91 mixed) and 107 (vivax 74, falciparum 20, mixed 13) required ICU admission. Common symptoms observed apart from fever were, oliguria (48), dyspnea(41), bleeding (29), hemoptysis (15) and petechial rash (13). Mean BUN and creatinine and PT INR of falciparum/mixed malaria patients was significantly higher and HCO3 and pH significantly lower than vivax patients. But PaO2/FiO2 of vivax patient was significantly lower as compared falciparum/mixed patients. There was no significant difference between two groups with regards to requirement of supportive treatment like inotropes (11/70 vs 5/30, p=0.858), mechanical ventilation (28/70 vs 7/30, p=0.17), platelet transfusion (24/70 vs 9/30, p=0.853) and renal replacement therapy (5/70 vs 3/30 p=0.936). Out of 100 patients, 21 patients expired. Mortality in mixed malaria group (4/12, 33.3%) and vivax group ( 16/70, 22.9%) was more as compared to falciparum group (1/18, 5.6%, < 0.05).

CONCLUSIONS

Incidence of Plasmodium vivax malaria is higher compared to falciparum malaria in hospitalized patients and higher percentage of these need ICU care. Most common complications of malaria are thrombocytopenia followed by renal failure, hepatic dysfunction, ARDS, shock and cerebral dysfunction respectively. Mortality was higher in vivax and mixed malaria compared to falciparum. Higher SOFA score (Sequential organ failure assessment score), lower GCS score (Glasgow coma scale), hypotension, ARDS and metabolic acidosis are predictors of mortality.

摘要

背景

尽管过去十年全球疟疾发病率有所下降,但它仍是急性发热患者死亡和发病的重要原因。许多复杂疟疾患者需要重症监护病房(ICU)护理。过去认为间日疟是一种良性疟疾形式,但现在间日疟也出现了所有疟疾并发症。

目的

  1. 确定在医学重症监护病房接受治疗的间日疟和恶性疟患者的比例。2. 比较这些患者的临床特征和疾病严重程度。3. 研究这些患者接受的治疗,包括器官支持需求,并比较间日疟和恶性疟患者的结局。

结果

在研究期间,共有932例患者被确诊为确诊疟疾(601例间日疟、240例恶性疟和91例混合感染),107例(间日疟74例、恶性疟20例、混合感染13例)需要入住ICU。除发热外观察到的常见症状有少尿(48例)、呼吸困难(41例)、出血(29例)、咯血(15例)和瘀点皮疹(13例)。恶性疟/混合感染疟疾患者的平均血尿素氮、肌酐和凝血酶原国际标准化比值显著高于间日疟患者,而碳酸氢根和pH值显著低于间日疟患者。但间日疟患者的氧合指数显著低于恶性疟/混合感染患者。两组在使用血管活性药物(11/70 vs 5/30,p = 0.858)、机械通气(28/70 vs 7/30,p = 0.17)、血小板输注(24/70 vs 9/30,p = 0.853)和肾脏替代治疗(5/70 vs 3/30,p = 0.936)等支持治疗需求方面无显著差异。100例患者中,21例死亡。混合疟组(4/12,33.3%)和间日疟组(16/70,22.9%)的死亡率高于恶性疟组(1/18,5.6%,<0.05)。

结论

住院患者中间日疟的发病率高于恶性疟,且其中较高比例的患者需要ICU护理。疟疾最常见的并发症分别是血小板减少症,其次是肾衰竭、肝功能障碍、急性呼吸窘迫综合征、休克和脑功能障碍。间日疟和混合疟的死亡率高于恶性疟。较高的序贯器官衰竭评估评分(SOFA评分)、较低的格拉斯哥昏迷量表评分(GCS评分)、低血压、急性呼吸窘迫综合征和代谢性酸中毒是死亡率的预测因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验